We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Teledyne Medical Microsystems (TMM), a leading global provider of engineering and manufacturing services for OEM medical device companies, announced today that it has chosen Quantum Method as its agency of record to help develop and execute its branding and communication strategies.
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that it has filed a Medical Device Licence Application with Health Canada to begin the commercialization of its SoftScan breast imaging
device.
Gary Macleod, Chief Executive Officer, of NIMS announced "that Non-Invasive Monitoring Systems, Inc. recently entered into an agreement with General Médica de Imágenes CxA" with an official address at Calle 8 #5 El Cacique, Santo Domingo, Dominican Republic to distribute NIMS's patent protected AT-101 Motion Platform and future home version of the AT-101 throughout the Dominican Republic.
AdvaMed has created a logo for device and diagnostics manufacturers to display indicating their intent to abide by the principles of the AdvaMed Code of Ethics on Interactions with Health Care Professionals.
Bayer HealthCare's diagnostics division has announced that the FDA has approved its fully automated test to detect antibodies for three strains of HIV.
The FDA published draft guidance June 19 to assist devicemakers in preparing for FDA's review of their premarket approval (PMA) applications and for coordinating inspections for PMA supplements.
A new prognostic test can help determine whether a prostate cancer patient will go on to have a recurrence of the disease, even if surrounding lymph nodes initially appear negative for cancer, according to a study by University of Southern California researchers.
Meridian Co., Ltd. announced that it has reached a major milestone in the execution of its strategic business plan of establishing a significant role in the 9 billion dollar aesthetic market in North America.